PuSH - Publikationsserver des Helmholtz Zentrums München

Menditto, E.* ; Costa, E.* ; Midao, L.* ; Bosnic-Anticevich, S.* ; Novellino, E.* ; Bialek, S.* ; Briedis, V.* ; Mair, A.* ; Rajabian-Soderlund, R.* ; Arnavielhe, S.* ; Bedbrook, A.* ; Czarlewski, W.* ; Annesi-Maesano, I.* ; Antò, J.M.* ; Devillier, P.* ; De Vries, G.* ; Keil, T.* ; Sheikh, A.* ; Orlando, V.* ; Larenas-Linnemann, D.* ; Cecchi, L.* ; De Feo, G.* ; Illario, M.* ; Stellato, C.* ; Fonseca, J.* ; Malva, J.* ; Morais-Almeida, M.* ; Pereira, A.M.* ; Todo-Bom, A.M.* ; Kvedariene, V.* ; Valiulis, A.* ; Bergmann, K.C.* ; Klimek, L.* ; Moesges, R.* ; Pfaar, O.* ; Zuberbier, T.* ; Cardona, V.* ; Mullol, J.* ; Papadopoulos, N.G.* ; Prokopakis, E.P.* ; Bewick, M.* ; Ryan, D.* ; Roller-Wirnsberger, R.E.* ; Tomazic, P.V.* ; Cruz, A.A.* ; Kuna, P.* ; Samolinski, B.* ; Fokkens, W.J.* ; Reitsma, S.* ; Bosse, I.* ; Fontaine, J.-F.* ; Laune, D.* ; Haahtela, T.* ; Toppila-Salmi, S.* ; Bachert, C.* ; Hellings, P.W.* ; Melén, E.* ; Wickman, M.* ; Bindslev-Jensen, C.* ; Eller, E.* ; O'Hehir, R.E.* ; Cingi, C.* ; Gemicioğlu, B.* ; Kalayci, O.* ; Ivancevich, J.C.* ; Bousquet, J.* ; MASK Study Group (Darsow, U.)

Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study.

Clin. Exp. Allergy 49, 442-460 (2019)
Postprint DOI PMC
Open Access Green
Background: Mobile technology may help to better understand the adherence to treatment. MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries.Objectives: To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App.Methods: An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from 1 January 2016 to 1 August 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach.Results: A total of 12143 users were registered. A total of 6949 users reported at least one VAS data recording. Among them, 1887 users reported >= 7 VAS data. About 1195 subjects were included in the analysis of adherence. One hundred and thirty-six (11.28%) users were adherent (MPR >= 70% and PDC <= 1.25), 51 (4.23%) were partly adherent (MPR >= 70% and PDC = 1.50) and 176 (14.60%) were switchers. On the other hand, 832 (69.05%) users were non-adherent to medications (MPR <70%). Of those, the largest group was non-adherent to medications and the time interval was increased in 442 (36.68%) users.Conclusion and clinical relevance: Adherence to treatment is low. The relative efficacy of continuous vs on-demand treatment for allergic rhinitis symptoms is still a matter of debate. This study shows an approach for measuring retrospective adherence based on a mobile app. This also represents a novel approach for analysing medication-taking behaviour in a real-world setting.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
4.741
1.415
33
32
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Adherence ; Mhealth ; Mobile Technology ; Observational Study ; Rhinitis ; Treatment; Controller Medication; K-anonymity; Asthma; Persistence; Validation; Therapy; Disease; Trial
Sprache englisch
Veröffentlichungsjahr 2019
HGF-Berichtsjahr 2019
ISSN (print) / ISBN 0954-7894
e-ISSN 1365-2222
Quellenangaben Band: 49, Heft: 4, Seiten: 442-460 Artikelnummer: , Supplement: ,
Verlag Wiley
Verlagsort 111 River St, Hoboken 07030-5774, Nj Usa
Begutachtungsstatus Peer reviewed
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Allergy
PSP-Element(e) G-505400-001
PubMed ID 30597673
Erfassungsdatum 2019-04-19